The results were presented at the American College of Phlebology's 24th Annual Congress in Orlando, Florida on November 5, and here today at the 37th Annual VEITH
Symposium on Vascular and Endovascular Issues.
Additional presentations at the VEITH Symposium featuring the Powerlink System are as follows:
We are delighted to announce data from our Powerlink XL clinical trial at the prestigious VEITH Symposium.
Nasdaq:ELGX) today reported that favorable Powerlink([R]) System clinical data was featured in two presentations on Saturday, November 17 at the 34th Annual VEITH Symposium in New York City.
These presentations underscore the fact that the Powerlink System provides important technology that can meet the expanding role of EVAR and we are exceptionally pleased that this message was delivered at the prestigious VEITH Symposium.
Professor of Surgery at UCLA School of Medicine and Chief of Vascular Surgery at Harbor-UCLA Medical Center, presented the data at the VEITH symposium(TM) in New York on Saturday, November 19.
We were exceptionally pleased with the positive four-year data presented at the VEITH symposium, which is an important conference in reaching thought leaders in the endovascular community," said Endologix President and CEO Paul McCormick.
Nasdaq:ELGX) today announced that two presentations at the 32nd Annual VEITH
symposium(TM) will highlight the Company's minimally invasive treatment for abdominal aortic aneurysms (AAA), the Powerlink(R) System.